FORMULATION STUDIES ON CYCLODEXTRIN COMPLEXES OF MELOXICAM

Journal Title: International Journal of Pharmacy and Technology - Year 2010, Vol 2, Issue 1

Abstract

b-Cyclodextrin (b-CD) and HP-b-Cyclodextrin (HP-b-CD) inclusion complexes of meloxicam (M) exhibited higher dissolution rates and dissolution efficiency values than the corresponding uncomplexed drug. The feasibility of formulating the b-cyclodextrin and P-b-cyclodextrin complexes of meloxicam (1:3) into tablet dosage forms is evaluated. Solid inclusion complexes of meloxicam prepared by kneading method were formulated into tablets by wet granulation and direct compression methods. All the tablets formulated employing b-cyclodextrin and HP-b-cyclodextrin complexes of meloxicam gave rapid and higher dissolution rates of when compared to that of meloxicam plain tablets. All the prepared tablets fulfilled the official (I.P.) disintegration time specification of uncoated tablets. Overall, tablets prepared by direct compression method disintegrate rapidly when compared to those prepared by wet granulation method. Analysis of dissolution data as per zero-order and first – order kinetic models indicated that the dissolution of meloxicam from all the tablets followed first-order kinetics. In both direct compression and wet granulation methods, tablets formulated employing cyclodextrin complexes (MT2, MT3, MT5, MT6) gave higher rates of dissolution (K1) and dissolution efficiency (DE30) values when compared to the corresponding tablets formulated with meloxicam as such (MT1, MT4). Among all the meloxicam tablets formulated, formulation MT2, which is based on M- βCD (1:3) kneaded complex, gave highest dissolution. A 25.66 fold increase in the dissolution rate of meloxicam was observed with MT2 when compared to its plain tablets ( MT1).

Authors and Affiliations

Nagabhushanam M. V

Keywords

Related Articles

SPECTROPHOTOMETRIC ESTIMATION OF SPARFLOXACIN IN BULK<br /> AND PHARHARMACEUTICAL DOSAGE FORMS

Two simple and sensitive visible Spectrophotometric methods [I and II] have been developed for the quantitative estimation of Sparfloxacin in bulk and Pharmaceutical dosage forms. Method-I is based on ion-pair complex fo...

IN-VIVO PHARMACOKINETIC STUDIES OF SOLID DISPERSIONS OF CELECOXIB

Dissolution rate and dissolution efficiency of poorly soluble non-steroidal anti inflammatory drugs (NSAIDs) could be markedly enhanced by solid dispersion technology. Solid dispersions of celecoxib (C) are subjected to...

ANTIDIABETIC ACTIVITY OF STEM BARK OF NEOLAMARCKIA CADAMBA IN ALLOXAN INDUCED DIABETIC RATS

Different doses of ethanolic fraction of stem bark of neolarckia cadamba were evaluated for hypoglycemic activity in normal and alloxan diabetic rats. The oral administration of ethanolic extract of 0.5g/kg body weight e...

SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NOVEL<br /> THIAZOLOQUINAZOLINE AS NEW CLASS OF H1-ANTIHISTAMINIC AGENT

A series of novel 6,7,8,9 tetra hydro-5H-5-(2'-hydroxy phenyl)-2-(4'-some substituted benzylidine)-3-(4-nitrophenyl amino) thiazolo quinazoline were synthesized the reaction with appropriate aromatic aldehydes and p –nit...

ASSAM BORA RICE STARCH AS DIRECTLY COMPRESSIBLE FILLERBINDER

Introduction: North-east India, including Assam, is recognized as a centre of origin of rice and is endowed with exceptionally rich rice diversity. Assam Bora rice (Oryza sativa L, Japonica variety), a group of glutinous...

Download PDF file
  • EP ID EP113294
  • DOI -
  • Views 163
  • Downloads 0

How To Cite

Nagabhushanam M. V (2010). FORMULATION STUDIES ON CYCLODEXTRIN COMPLEXES OF MELOXICAM. International Journal of Pharmacy and Technology, 2(1), 89-102. https://europub.co.uk./articles/-A-113294